Patent · US Revoked

Tropane analogs and methods for inhibition of monoamine transport

US6291512A · kind A · utility

0Cited by
7References
37Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 27, 2000
Grant dateSep 18, 2001
Priority date
Expiry dateSep 27, 2020

Classification

  • Technology area (CPC —)General

Abstract

New tropane analogs that bind to monoamine transporters are described, particularly, 8-aza, 8carbo and 8-oxo tropanes having 6- or 7- substituents. The compounds of the present invention can be racemic, pure R-enantiomers, or pure S-enantiomers. Certain preferred compounds of the present invention have a high selectivity for the DAT versus the SERT. Also described are pharmaceutical therapeutic compositions comprising the compounds formulated in a pharmaceutically acceptable carrier and a method for inhibiting 5-hydroxy-tryptamine reuptake of a monoamine transporter by contacting the monoamine transporter with a 5-hydroxytryptamine reuptake inhibiting amount of a compound of the present invention. Preferred monoamine transporters for the practice of the present invention include the dopamine transporter, the serotonin transporter and the norepinephrine transporter.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.